Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opexa Therapeutics Inc (NASDAQ:OPXA)

0.86
Delayed Data
As of Dec 08
 -0.0302 / -3.39%
Today’s Change
0.50
Today|||52-Week Range
4.93
-68.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues726.3K726.3K726.3K726.3K
 
 
 
 
 
Depreciation And Amortization71.4K72.6K65.7K52.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses3.1M2.8M2.8M2.7M
 
 
 
 
 
Research And Development2.2M1.8M1.8M2.2M
 
 
 
 
 
Total Operating Expenses3.1M2.9M2.8M2.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.4M-2.2M-2.1M-2.0M
 
 
 
 
 
Interest Expense On Debt--1.4K758.00224.00
 
 
 
 
Other Expenses35.9K2.1K2.7K-2.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.4M-2.2M-2.1M-2.0M
 
 
 
 
 
Net Income-2.4M-2.2M-2.1M-2.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.0M7.0M7.0M7.1M
 
 
 
 
 
Shares To Calculate EPS Diluted7.0M7.0M7.0M7.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.30-$0.31-$0.30-$0.28
 
 
 
 
 
EPS Diluted-$0.34-$0.31-$0.30-$0.28